Template:Cardiomyopathy: Difference between revisions
Jump to navigation
Jump to search
No edit summary Tag: Manual revert |
No edit summary |
||
Line 185: | Line 185: | ||
! | ! | ||
|- bgcolor="CadetBlue" | |||
! | |||
Guidelines | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
[[Cardiomyopathy 2023 ESC Guideline Recommendations|2023 ESC Guideline Recommendations]] | |||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Cardiomyopathy | [[Cardiomyopathy 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy|2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="CadetBlue" | |- bgcolor="CadetBlue" | ||
! | ! |
Latest revision as of 06:57, 13 November 2023
Cardiomyopathy Microchapters |
Diagnosis |
---|
Treatment |
Guidelines |
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy |
Case Studies |
Cardiomyopathy On the Web |
American Roentgen Ray Society Images of Cardiomyopathy |